Perfil de la empresa · Healthcare

Henan Lingrui Pharmaceutical Co Ltd

600285 · Shanghái
País / Región
China
Fecha de salida a bolsa
14 de septiembre de 2000
Empleados
2789
Buffett Score
87/100
Excelente
Capitalización10,76 mil M CNY
Ingresos (TTM)3902,16 M CNY
EBITDA949,62 M CNY
Margen neto19,99 %
ROE24,63 %
PER (TTM)13,85
PER previsto25,19
BPA1,37 CNY
Rentabilidad por dividendo5,89 %
Rango de 52 semanas18,51 CNY – 23,65 CNY

Datos de EODHD, mostrados en la moneda de reporte; solo a título informativo, no constituye asesoramiento de inversión.

Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Medical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, nutritional supplements, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules. The company also engages in industrial and real estate investment; technology research and development; ecological agriculture; and high-tech activities. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Xinyang, China.

Historia

PróximamenteEsta sección se está completando; vuelve pronto.

Posición en el sector

PróximamenteEsta sección se está completando; vuelve pronto.

Aún no hay análisis sobre este valor en tu idioma.